Literature DB >> 8955922

Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.

M A Yenari1, J T Palmer, G H Sun, A de Crespigny, M E Mosely, G K Steinberg.   

Abstract

Diffusion-weighted magnetic resonance imaging (DWI) is capable of noninvasively imaging acute cerebral ischemia. We demonstrate the utility of this technique by evaluating SNX-111, a novel N-type calcium channel blocker with potential neuroprotective properties, in a rodent model of transient focal ischemia. Twenty-four Sprague-Dawley rats weighing between 310-350 g underwent occlusion of the middle cerebral artery (MCAO) for 105 min followed by 22.5 h of reperfusion. Thirty minutes following MCAO, animals were randomized to receive SNX-111 5 mg/kg intravenously over 1 h vs. placebo. DWI and T2-weighted MRIs (T2W) were performed at 0.5, 1.5 and 24 h after the onset of ischemia. Area fractions of increased signal intensity on the DWI and T2W images were measured. DWI area fractions at 1.5 and 24 h were also normalized to the initial, pre-treatment scans. Apparent diffusion coefficients (ADC) were calculated from fitted maps. Tri-phenyl tetrazolium chloride (TTC) staining was performed on brains at 24 h and infarct area fractions were measured. SNX-111 treated animals showed significantly improved 1.5-h DWI scan ratios compared to controls (ratios of 1.06 +/- 0.25 vs. 2.98 +/- 0.78 SNX vs. controls respectively, P < 0.05). A trend toward improved DWI ratios was seen by 24 h in the SNX-111 group (2.5 +/- 0.75 vs. 4.12 +/- 1.6, N.S.) DWI, T2W and TTC area fractions at 24 h also showed trends favoring a neuroprotective effect of SNX-111. Bright areas on DWI corresponded to ADC decreases of about 30% compared to the non-ischemic hemisphere. These decreases were the same in both treatment groups and at each time point. DWI, T2W and TTC area fractions at 24 h were strongly correlated (r = 0.98, DWI and TTC; r = 0.99, T2W and TTC; r = 0.97, T2W and DWI, P < 0.0001). We conclude that in this ischemic model, SNX-111 provides early neuroprotection and that serial DWI is a useful way of demonstrating this.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955922     DOI: 10.1016/s0006-8993(96)00808-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Perinatal stroke: a case-based review.

Authors:  Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2011-06-25       Impact factor: 3.183

Review 2.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

3.  Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke.

Authors:  M G Lansberg; V N Thijs; M W O'Brien; J O Ali; A J de Crespigny; D C Tong; M E Moseley; G W Albers
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

4.  Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression.

Authors:  Damian G Wheeler; Rachel D Groth; Huan Ma; Curtis F Barrett; Scott F Owen; Parsa Safa; Richard W Tsien
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

5.  Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes.

Authors:  Joshua Y Chua; Arjun V Pendharkar; Nancy Wang; Raymond Choi; Robert H Andres; Xavier Gaeta; Jian Zhang; Mike E Moseley; Raphael Guzman
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

Review 6.  Limiting neurological damage after stroke: a review of pharmacological treatment options.

Authors:  S J Read; T Hirano; S M Davis; G A Donnan
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 7.  The mechanisms of brain ischemic insult and potential protective interventions.

Authors:  Zhao-Hui Guo; Feng Li; Wei-Zhi Wang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

8.  99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody.

Authors:  Francis G Blankenberg; Judy Kalinyak; Liping Liu; Maya Koike; Danye Cheng; Michael L Goris; Allan Green; Jean-Luc Vanderheyden; David C Tong; Midori Anne Yenari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-14       Impact factor: 9.236

Review 9.  Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

Authors:  Vernon D Twede; George Miljanich; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Curr Opin Drug Discov Devel       Date:  2009-03

10.  Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V.

Authors:  Carina Mari; Murat Karabiyikoglu; Michael L Goris; Jonathan F Tait; Midori Anne Yenari; Francis G Blankenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-21       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.